Literature DB >> 18242015

Time dependencies in perfluorooctylacids disposition in rat and monkeys: a kinetic analysis.

Yu-Mei Tan1, Harvey J Clewell, Melvin E Andersen.   

Abstract

Perfluorooctanoate (PFOA) and perfluorooctanesulfonate (PFOS) are surfactants that have been used for various industrial and consumer applications. The widespread exposure and persistence of PFOA and PFOS in humans have caused these chemicals to be the subject of intense kinetic and toxicity studies. To identify the biological determinants of the species different in elimination observed in kinetic studies, we incorporated time-dependent descriptions for free fraction in plasma and for volume of distribution into an earlier pharmacokinetic model to simulate the time course behaviors of PFOA and PFOS in monkeys and rats. The structurally similar model for monkeys and rats also allows for examination of the complex kinetics observed in animal studies. A higher estimated liver:blood partition coefficient in the rat and additional binding in rat liver suggest that PFOS retention in liver occurs in rats but not in monkeys. Higher liver:blood partition coefficient and renal filtration suggest that PFOS is retained longer in tissues compared to PFOA. A much lower renal resorption may explain the fast elimination of PFOA from plasma observed in female compared to male rats. Understanding these cross-species, cross-compound, and cross-gender difference is an important step in the future development of a human model for these compounds.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18242015     DOI: 10.1016/j.toxlet.2007.12.007

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  10 in total

Review 1.  Impact of perfluorochemicals on human health and reproduction: a male's perspective.

Authors:  C Foresta; S Tescari; A Di Nisio
Journal:  J Endocrinol Invest       Date:  2017-11-17       Impact factor: 4.256

2.  Effects of perfluorooctanesulfonate and perfluorobutanesulfonate on the growth and sexual development of Xenopus laevis.

Authors:  Qin-Qin Lou; Yin-Feng Zhang; Zhen Zhou; Ya-Li Shi; Ya-Nan Ge; Dong-Kai Ren; Hai-Ming Xu; Ya-Xian Zhao; Wu-Ji Wei; Zhan-Fen Qin
Journal:  Ecotoxicology       Date:  2013-08-02       Impact factor: 2.823

3.  Physiologically based pharmacokinetic modeling of human exposure to perfluorooctanoic acid suggests historical non drinking-water exposures are important for predicting current serum concentrations.

Authors:  Rachel Rogers Worley; Xiaoxia Yang; Jeffrey Fisher
Journal:  Toxicol Appl Pharmacol       Date:  2017-07-03       Impact factor: 4.219

4.  Rate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West Virginia.

Authors:  Scott M Bartell; Antonia M Calafat; Christopher Lyu; Kayoko Kato; P Barry Ryan; Kyle Steenland
Journal:  Environ Health Perspect       Date:  2010-02       Impact factor: 9.031

5.  Development of PBPK models for PFOA and PFOS for human pregnancy and lactation life stages.

Authors:  Anne E Loccisano; Matthew P Longnecker; Jerry L Campbell; Melvin E Andersen; Harvey J Clewell
Journal:  J Toxicol Environ Health A       Date:  2013

6.  Variability and epistemic uncertainty in water ingestion rates and pharmacokinetic parameters, and impact on the association between perfluorooctanoate and preeclampsia in the C8 Health Project population.

Authors:  Raghavendhran Avanasi; Hyeong-Moo Shin; Veronica M Vieira; Scott M Bartell
Journal:  Environ Res       Date:  2016-01-19       Impact factor: 6.498

7.  Roles of rat renal organic anion transporters in transporting perfluorinated carboxylates with different chain lengths.

Authors:  Yi M Weaver; David J Ehresman; John L Butenhoff; Bruno Hagenbuch
Journal:  Toxicol Sci       Date:  2009-11-13       Impact factor: 4.849

8.  Accumulation and clearance of perfluorooctanoic acid (PFOA) in current and former residents of an exposed community.

Authors:  Ryan Seals; Scott M Bartell; Kyle Steenland
Journal:  Environ Health Perspect       Date:  2010-09-22       Impact factor: 9.031

9.  Assessment of a mouse xenograft model of primary colorectal cancer with special reference to perfluorooctane sulfonate.

Authors:  Jeffrey H Wimsatt; Caitlin Montgomery; Laurel S Thomas; Charity Savard; Rachel Tallman; Kim Innes; Nezar Jrebi
Journal:  PeerJ       Date:  2018-11-02       Impact factor: 2.984

10.  Development of a Gestational and Lactational Physiologically Based Pharmacokinetic (PBPK) Model for Perfluorooctane Sulfonate (PFOS) in Rats and Humans and Its Implications in the Derivation of Health-Based Toxicity Values.

Authors:  Wei-Chun Chou; Zhoumeng Lin
Journal:  Environ Health Perspect       Date:  2021-03-17       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.